Search results for "COI"

showing 10 items of 1683 documents

 A Mechanistic Approach to theIn VivoAnti-Inflammatory Activity of Sesquiterpenoid Compounds Isolated fromInula viscosa

2001

The present study was designed to examine the anti-inflammatory activity of the sesquiterpenoids ilicic acid and inuviscolide, isolated from Inula viscosa, on cell degranulation, leukotriene biosynthesis, neurogenic drive and glucocorticoid-like interactions. Swiss female mice were used to measure the ear oedema induced by phorbol esters or ethyl phenylpropiolate (EPP), and the paw oedema induced by phospholipase A(2) (PLA(2)) or serotonin. Drug treatment consisted of one topically-applied dose in the ear models and a subcutaneous or intraperitoneal injection in the paw models. Quantitative analysis of leukotriene B(4) (LTB(4)) formation was performed on rat peritoneal neutrophils by high p…

medicine.drug_classLeukotriene B4medicine.medical_treatmentIntraperitoneal injectionPharmaceutical SciencePharmacologyBiologyPharmacognosyLeukotriene B4Cell DegranulationAnti-inflammatoryAnalytical ChemistryInhibitory Concentration 50MiceStructure-Activity Relationshipchemistry.chemical_compoundPhospholipase A2In vivoDrug DiscoverymedicineAnimalsDrug InteractionsGlucocorticoidsInflammationPharmacologyPhospholipase ADose-Response Relationship DrugMolecular StructureAnti-Inflammatory Agents Non-SteroidalOrganic ChemistryComplementary and alternative medicineBiochemistryMechanism of actionchemistrybiology.proteinMolecular MedicineFemaleInulaPlant Preparationsmedicine.symptomSesquiterpenesPhytotherapyPlanta Medica
researchProduct

In Vivo Studies on the Anti-Inflammatory Activity of Pachymic and Dehydrotumulosic Acids

2000

Pachymic and dehydrotumulosic acids were studied in different models of acute and chronic inflammation. They proved to be active in most of the methods applied. None of them were active against arachidonic acid-induced ear edema. Dehydrotumulosic acid significantly diminished the mouse ear edema induced by ethyl phenylpropiolate, while pachymic acid was ineffective. When the putative corticoid-like mechanism of both compounds was explored, pachymic acid activity was partially abolished by the glucocorticoid receptor antagonist progesterone, but dehydrotumulosic acid activity was not affected. In vivo experiments demonstrated the inhibition by both principles of the phospholipase A2 (PLA2)-i…

medicine.drug_classPharmaceutical SciencePharmacologyAnti-inflammatoryAnalytical ChemistryMicechemistry.chemical_compoundPhospholipase A2In vivoDrug DiscoverymedicineAnimalsPharmacologybiologyAntiglucocorticoidAnti-Inflammatory Agents Non-SteroidalOrganic ChemistryFungiBiological activityTriterpenesExtravasationComplementary and alternative medicinechemistryBiochemistryMechanism of actionEnzyme inhibitorbiology.proteinMolecular MedicineFemalemedicine.symptomPlanta Medica
researchProduct

COVID-19 infection and glucocorticoids: update from the Italian Society of Endocrinology Expert Opinion on steroid replacement in adrenal insufficien…

2020

In November 2019, the Italian Society of Endocrinology (SIE) has published a consensus statement on the tailoring of glucocorticoid replacement in adrenal insufciency [1]. A few months later, a novel severe acute respiratory syndrome coronavirus (SARS-CoV2) has been recognized as responsible for COVID-19. The outbreak has now reached pandemic level, with a high global mortality rate [2]. From February on, Italy has experienced an exponential rise in the infected which is estimated to reach 200,000 people, with an overall lethality of approximately 10% [3]. A recent Chinese series of nearly 50,000 patients with confrmed COVID-19 infection found that approximately one-out-of-fve (19%) evolve …

medicine.medical_specialty2019-20 coronavirus outbreakConsensusCoronavirus disease 2019 (COVID-19)Hormone Replacement TherapyEndocrinology Diabetes and MetabolismSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Pneumonia ViralConsensuEndocrinologyGlucocorticoidmedicineAdrenal insufficiencyHumansSteroids.Hormone replacement therapyViralIntensive care medicinePandemicsAdrenal insufficiency; COVID-19; Glucocorticoids; SARS-CoV2GlucocorticoidsPandemicbusiness.industryCoronavirus InfectionCOVID-19Pneumoniamedicine.diseaseCOVID-19 Drug TreatmentItalyExpert opinionSARS-CoV2SteroidsbusinessCoronavirus InfectionsCoronavirus InfectionsAdrenal insufficiencyHuman
researchProduct

Use of corticosteroids in Coronavirus disease 2019 pneumonia: A systematic review of the literature

2020

The aim was to investigate the effectiveness of glucocorticoid therapy in patients with COVID-19. A systematic search of the literature across nine databases was conducted from inception until 15th March 2020, following the PRISMA guidelines. Patients with a validated diagnosis of COVID-19 and using corticosteroids were included, considering all health outcomes. Four studies with 542 Chinese participants were included. Two studies reported negative findings regarding the use of corticosteroids in patients with COVID-19, i.e., corticosteroids had a detrimental impact on clinical outcomes. One study reported no significant association between the use of corticosteroids and clinical outcomes. …

medicine.medical_specialtyARDSCoronavirus disease 2019 (COVID-19)SARS-Cov-2Coronavirucoronavirus030204 cardiovascular system & hematologyHealth outcomescorticosteroids03 medical and health sciences0302 clinical medicineInternal medicineMedicineCorticosteroidpneumoniaIn patient030212 general & internal medicinelcsh:R5-920business.industryCOVID-19General Medicinemedicine.diseasemethylprednisolonePneumoniaMethylprednisoloneGlucocorticoid therapyMedicineARDSRisk of deathSystematic ReviewCOVID-19 coronavirus corticosteroids methylprednisolone pneumonia ARDS SARS-Cov-2businesslcsh:Medicine (General)medicine.drug
researchProduct

Type 1A endoleak detachable coil embolization after endovascular aneurysm sealing: Case report

2021

Introduction Endovascular aneurysm sealing (EVAS) with the Nellix system was introduced to reduce endovascular aneurysm repair (EVAR) perioperative complications, especially endoleaks. Herein we report a case of successful type 1A endoleak managed with detachable coils embolization after EVAS. Presentation of case A 77-year-old male was referred for abdominal pain. The angio-CT scan confirmed the previous EVAS procedure and showed a type Is2 endoleak below the right renal artery resulting in a 2.5 cm aortic blister with contrast medium filling the space between the aortic wall and the endobags. The patient was considered unfit for conventional open surgery and an endovascular approach with …

medicine.medical_specialtyAbdominal painEndoleakmedicine.medical_treatmentCase ReportEndovascular aneurysm repairSettore MED/22 - Chirurgia Vascolare03 medical and health sciences0302 clinical medicineAneurysmMedicineLocal anesthesiaEmbolizationRight Renal Arterybusiness.industryCoil embolizationPerioperativemedicine.diseaseAneurysmSurgeryContrast medium030220 oncology & carcinogenesis030211 gastroenterology & hepatologySurgerymedicine.symptombusinessNellix
researchProduct

Management of oral Graft versus Host Disease with topical agents: a systematic review

2015

Background: Oral Graft-versus-Host Disease (oGvHD) is a common complication of haematopoietic stem cell transplantation. Choosing the right topical application to be used intra orally can be a challenge. Consequently, the aim of this work is to review the effectiveness and safety of topical agents currently used in the management of the inflammatory mucosal lesions encountered in oGVHD. Material and Methods: We carried out electronic searches of publications up to May 2015 of the databases Pubmed, National Library of Medicine’s Medline, Embase and the Cochrane Central Register of Controlled Clinical trials to identify potentially relevant studies (keywords: “oral”, “graft”, “versus”, “host”…

medicine.medical_specialtyAdministration TopicalGraft vs Host DiseaseOdontologíaReviewDisease03 medical and health sciences0302 clinical medicinemedicineHumansIntensive care medicineGlucocorticoidsGeneral Dentistrybusiness.industryMucosal lesions030206 dentistryMedically compromised patients in Dentistry:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseCiencias de la saludSurgeryTransplantationGraft-versus-host diseaseOtorhinolaryngologyTopical agents030220 oncology & carcinogenesisUNESCO::CIENCIAS MÉDICASSurgeryStem cellMouth DiseasesbusinessComplicationImmunosuppressive Agents
researchProduct

The effect of two sulphur-containing pesticides, fenitrothion and endosulfan, on glutathione (GSH) content and on GSH S-transferase and gamma-glutamy…

1988

The glutathione (GSH) system of Procambarus clarkii (P.c.), the American red crayfish, is used as a marker of the effects of Fenitrothion (FT) and Endosulfan (ES), organophosphorus and organochlorinated insecticides, respectively. This system has been shown to be sensitive to different heavy metals poisoning, thus it has a double interest as marker for environmental contamination and as a potential source of xenobiotics or their metabolites to humans, since it is being fished commercially. The GSH content of the organ decreased 24 h after treatment with FT. FT promotes a 2-fold induction of GSH S-transferase (GST) activity at 6 h which is followed by a decrease of it at 24 h. The latter coi…

medicine.medical_specialtyAstacoideaIn Vitro TechniquesMedian lethal doseFenitrothionLethal Dose 50chemistry.chemical_compoundExocrine GlandsInternal medicinemedicineAnimalsPharmacology (medical)PancreasEndosulfanGlutathione TransferaseProcambarus clarkiibiologyGlutathioneFenitrothiongamma-Glutamyltransferasebiology.organism_classificationCrayfishGlutathioneEndocrinologychemistryBiochemistryLiverHepatopancreasXenobioticEndosulfanDrug metabolism and drug interactions
researchProduct

Dual specificity phosphatase 1 knockout mice show enhanced susceptibility to anaphylaxis but are sensitive to glucocorticoids.

2007

Dual specificity phosphatase DUSP1 (otherwise known as mitogen-activated phosphatase 1 or MKP-1) dephosphorylates MAPKs, particularly p38, and negatively regulates innate immunity. Recent studies have shown that the DUSP1 gene is transcriptionally up-regulated by glucocorticoids (GCs) and that the antiinflammatory action of GCs is impaired in DUSP1-/- mice. Here we show that GC-mediated dephosphorylation of ERK-1 and ERK-2 activated by IgE receptor cross-linking is unimpaired in bone marrow-derived mast cells (BMMCs) of DUSP1-/- mice. Dephosphorylation of phospho-p38 MAPK is impaired but only at early times of GC treatment. Proinflammatory cytokine and chemokine gene expression (CCL2, IL-6,…

medicine.medical_specialtyChemokinePhosphataseImmunoglobulin Ep38 Mitogen-Activated Protein KinasesProinflammatory cytokineDephosphorylationMiceEndocrinologyInternal medicineSepsisDual-specificity phosphatasemedicineAnimalsGenetic Predisposition to DiseaseMolecular BiologyAnaphylaxisGlucocorticoidsMice KnockoutMitogen-Activated Protein Kinase 1Mice Inbred C3HMitogen-Activated Protein Kinase 3biologyInterleukin-6Tumor Necrosis Factor-alphaDegranulationDual Specificity Phosphatase 1General MedicineMice Inbred C57BLEndocrinologyGene Expression RegulationMice Inbred DBAbiology.proteinCytokinesTumor necrosis factor alphaMolecular endocrinology (Baltimore, Md.)
researchProduct

Management of Coronary Artery Perforation

2020

Coronary artery perforation (CAP) is a rare but potentially life-threatening complication of percutaneous coronary intervention (PCI), however if recognized and managed promptly, its adverse consequences can be minimized. Risk factors for CAP include the use of advanced PCI technique (such as atherectomy and chronic total occlusion interventions) and treatment of severely calcified lesions. There are 3 major types of CAP depending on location: (a) large vessel perforation, (b) distal vessel perforation, and (c) collateral perforation. Large vessel perforation is usually treated with implantation of a covered stent, whereas distal and collateral vessel perforations are usually treated with c…

medicine.medical_specialtyCoronary artery perforationmedicine.medical_treatmentPerforation (oil well)Coronary Artery DiseaseCoil030204 cardiovascular system & hematologyCoronary AngiographyCovered stentCalcificationPercutaneous coronary interventionAtherectomyAnticoagulation03 medical and health sciencesPericardial tamponade0302 clinical medicineHumansMedicine030212 general & internal medicineEmbolizationCoronary Artery Perforationbusiness.industryPercutaneous coronary interventionGeneral Medicinemedicine.diseaseCoronary VesselsSurgeryTreatment OutcomeHeart InjuriesConventional PCIStentsCardiology and Cardiovascular MedicinebusinessComplicationCalcificationCardiovascular Revascularization Medicine
researchProduct

The Influence of Infection and Colonization on Outcomes in Inpatients With COVID-19 : Are We Forgetting Something?

2021

The COVID-19 epidemic has been a great challenge to health systems and especially hospitals. A prospective observational epidemiological study was planned as of February 26, 2020 in a tertiary hospital in the Valencia region. The total number of patients followed up with complete information during the first year was 2,448. Among other variables, the comorbidities of the patients were collected (and grouped in the Charson index), the stay in the intensive care unit (ICU), the co-infections, and the colonizations. Data on nosocomial infections due to said virus were also collected. The median days from the onset of symptoms to diagnosis were 4 + 4.6, while an additional 4.4 days had to pass …

medicine.medical_specialtyCoronavirus disease 2019 (COVID-19)COVID epidemiologyMedicina preventivaEpidemiologymedicineHumansrisk factorsColonizationEpidemiologiaOriginal ResearchInpatientsForgettingbusiness.industrySARS-CoV-2Public Health Environmental and Occupational HealthCOVID-19germ colonizationCandida aurismedicine.diseaseComorbiditySalut públicaIntensive Care UnitsCandida aurisdisease managementEmergency medicineCoinfectionObservational studyPublic HealthPublic aspects of medicineRA1-1270business
researchProduct